CHD 56 15 NOV 32 Price on September 24, 2024
17136MAC6 | 106.79 3.71 3.60% |
If you're considering investing in 17136MAC6 Bond, it is important to understand the factors that can impact its price. As of today, the current price of 17136MAC6 stands at 106.79, as last reported on the 27th of December, with the highest price reaching 106.79 and the lowest price hitting 106.79 during the day. CHD 56 15 secures Sharpe Ratio (or Efficiency) of -0.0184, which signifies that the bond had a -0.0184% return per unit of price deviation over the last 3 months. CHD 56 15 NOV 32 exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 17136MAC6's Variance of 0.4165, mean deviation of 0.3643, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide.
17136MAC6 Bond price history is provided at the adjusted basis, taking into account all of the recent filings.
17136MAC6 |
Sharpe Ratio = -0.0184
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 17136MAC6 |
Estimated Market Risk
0.65 actual daily | 5 95% of assets are more volatile |
Expected Return
-0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average 17136MAC6 is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 17136MAC6 by adding 17136MAC6 to a well-diversified portfolio.
Related Headline
Ihuman Headline on 24th of September 2024
Zevra Therapeutics to Present Top-Line Data from the Phase 2... by finance.yahoo.com
KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study CELEBRATION, Fla., Sept. 24, 2024 -- Zevra Therapeutics, Inc. a commercial-stage rare disease therapeutics company, today announced that Rene Braeckman, Ph.D., Zevras Senior Vice President of Clinical Development, will present top-line data from the placebo-controlled, double-blind, randomized wit
17136MAC6 Valuation on September 24, 2024
It is possible to determine the worth of 17136MAC6 on a given historical date. On September 24, 2024 17136MAC6 was worth 108.38 at the beginning of the trading date compared to the closed value of 108.38. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of 17136MAC6 bond. Still, in general, we apply an absolute valuation method to find 17136MAC6's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of 17136MAC6 where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against 17136MAC6's related companies.
Open | High | Low | Close | Volume | |
108.22 | 108.22 | 108.22 | 108.22 | 1.00 | |
09/24/2024 | 108.38 | 108.38 | 108.38 | 108.38 | 1.00 |
107.84 | 107.84 | 107.84 | 107.84 | 1.00 |
Backtest 17136MAC6 | | | 17136MAC6 History | Previous | Next |
17136MAC6 Trading Date Momentum on September 24, 2024
On September 26 2024 CHD 56 15 NOV 32 was traded for 107.84 at the closing time. The highest price during the trading period was 107.84 and the lowest recorded bid was listed for 107.84 . There was no trading activity during the period 1.0. Lack of trading volume on September 26, 2024 contributed to the next trading day price decline. The trading price change to the next closing price was 0.50% . The overall trading delta to the current price is 1.27% . |
About 17136MAC6 Bond history
17136MAC6 investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for 17136MAC6 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CHD 56 15 will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing 17136MAC6 stock prices may prove useful in developing a viable investing in 17136MAC6
17136MAC6 Bond Technical Analysis
17136MAC6 technical bond analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, bond market cycles, or different charting patterns.
Price Boundaries
17136MAC6 Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
CHD 56 15 NOV 32 cannot be verified against its exchange. Please verify the symbol is currently traded on Bond Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
17136MAC6 December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how 17136MAC6 bond reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading 17136MAC6 shares will generate the highest return on investment. By undertsting and applying 17136MAC6 bond market strength indicators, traders can identify CHD 56 15 NOV 32 entry and exit signals to maximize returns
17136MAC6 Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for 17136MAC6's price direction in advance. Along with the technical and fundamental analysis of 17136MAC6 Bond historical price patterns, it is also worthwhile for investors to track various predictive indicators of 17136MAC6 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.02) | |||
Total Risk Alpha | (0.06) | |||
Treynor Ratio | 3.71 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in 17136MAC6 Bond
17136MAC6 financial ratios help investors to determine whether 17136MAC6 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 17136MAC6 with respect to the benefits of owning 17136MAC6 security.